Abstract
Following 2 highly successful editions and a cancellation in 2020 due to the COVID-19 pandemic, the European Association for Cancer Research (EACR) resumes its 'Defense is the Best Attack: Immuno-Oncology Breakthroughs' conference in 2021 with its third edition as a worldwide virtual event. The meeting covered the latest advances in the field of immuno-oncology, ranging from preclinical research to pre- and postmarketing studies. The covered topics included identification of new actionable targets, use of precision medicine as a tool to improve response rates to current treatments, and modulation of the tumor microenvironment to promote anticancer immune responses. Copyright © 2021 Clarivate Analytics.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
